Aurora Cannabis Reports Q2 Fiscal 2025 Results

TL;DR

Aurora Cannabis (ACB) dropped its Q2 FY25 results Nov 6. Check the news release for details.

AI Summary

Aurora Cannabis Inc. announced its fiscal 2025 second quarter results on November 6, 2024. The company, led by CEO Miguel Martin, is incorporated in Alberta, Canada, and trades on NASDAQ and TSX under the ticker ACB.

Why It Matters

This filing provides investors with an update on Aurora Cannabis's financial performance for the second quarter of fiscal year 2025, impacting their investment decisions.

Risk Assessment

Risk Level: medium — Aurora Cannabis operates in the highly regulated and competitive cannabis industry, which presents inherent risks.

Key Players & Entities

• Aurora Cannabis Inc. (company) — Registrant
• Miguel Martin (person) — Chief Executive Officer
• November 6, 2024 (date) — Filing Date and News Release Date
• NASDAQ | TSX: ACB (company) — Stock Ticker

FAQ

From the Filing

0001279569-24-001335.txt : 20241106 0001279569-24-001335.hdr.sgml : 20241106 20241106073440 ACCESSION NUMBER: 0001279569-24-001335 CONFORMED SUBMISSION TYPE: 6-K PUBLIC DOCUMENT COUNT: 3 CONFORMED PERIOD OF REPORT: 20241106 FILED AS OF DATE: 20241106 DATE AS OF CHANGE: 20241106 FILER: COMPANY DATA: COMPANY CONFORMED NAME: AURORA CANNABIS INC CENTRAL INDEX KEY: 0001683541 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: A1 FISCAL YEAR END: 0331 FILING VALUES: FORM TYPE: 6-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-38691 FILM NUMBER: 241429254 BUSINESS ADDRESS: STREET 1: 2207 90B STREET SW CITY: EDMONTON STATE: A0 ZIP: T6X 1V8 BUSINESS PHONE: 604-362-5207 MAIL ADDRESS: STREET 1: 409 GRANVILLE STREET STREET 2: SUITE 1700 CITY: VANCOUVER STATE: A1 ZIP: V6C 1T2 6-K 1 aurora_6k.htm FORM 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of November 2024 Commission File No. 001-38691 AURORA CANNABIS INC. (Translation of registrant's name into English) 2207 90B St. SW Edmonton, Alberta T6X 1V8 Canada (Address of principal executive office) Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F Form 20-F ☐ Form 40-F ☒ SUBMITTED HEREWITH Exhibits Description 99.1 News Release dated November 6, 2024 SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. AURORA CANNABIS INC. /s/ Miguel Martin Miguel Martin Chief Executive Officer Date: November 6, 2024 EX-99.1 2 ex991.htm NEWS RELEASE DATED NOVEMBER 6, 2024 Exhibit 99.1 Aurora Cannabis Announces Fiscal 2025 Second Quarter Results NASDAQ | TSX: ACB Record Adjusted EBITDA 1 of $10.1 Million, a YoY increase of 210% Quarterly Net Revenue 1 up 29% YoY to $81.1 Million, with 41% growth in Global Medical Cannabis Re-Affirms Target of Positive Free Cash Flow 1 in the Quarter Ending December 31, 2024 Maintains Strong Balance Sheet with ~$152 Million of Cash and a Debt-Free Cannabis Business 2 EDMONTON, AB, Nov. 6, 2024 /CNW/ - Aurora Cannabis Inc. (the "Company" or "Aurora" ) (NASDAQ: ACB) (TSX: ACB), a leading Canada-based global medical cannabis company, today announced its financial and operational results for the second quarter fiscal 2025. "Our strong quarterly results demonstrate Aurora's leadership in global medical cannabis and ability to capitalize on opportunities within rapidly growing markets such as Australia, Germany, Poland, and the UK. International revenue increased 93% to $35 million, exceeding Canadian Medical revenue for the first time, and contributing 57% to total global medical cannabis revenue. The Bevo plant propagation segment also grew a robust 21% during its seasonally lowest quarter, proving the efficacy of our diversified operating model," said Chairman and Chief Executive Officer Miguel Martin. "With two quarters remaining in the fiscal year, we are proud to have delivered record adjusted EBITDA 1 and believe fiscal 2025 is anchored by our commitment to strategic growth, operational excellence, and the continued strength of our balance sheet," Mr. Martin concluded. 1 This press release includes certain non-GAAP financial measures, which are intended to supplement, not substitute for, comparable GAAP financial measures. See "Non-GAAP Measures" below for reconciliations of non-GAAP financial measures to GAAP financial measures. 2 Aurora's only remaining debt is non-recourse debt of $57.5 million relating to Bevo Farms Ltd as detailed in the FY2025 Q2 Financial Statements. Second Quarter 2025 Highlights (Unless otherwise stated, comparisons a